Table 4.
Lumbar spine BMDa β±SE | p value | |
---|---|---|
Model R2 | 28.6 % | |
Gender | −0.0587±0.0056 | <0.001* |
Ethnicity | <0.001* | |
Mexican (ref) | – | |
Hispanic and other | 0.0142±0.0114 | |
White | 0.0290±0.0073 | |
Black | 0.0726±0.0090 | |
Income | 0.044* | |
Level 1 (ref) | – | |
Level 2 | 0.0229±0.0067 | |
Level 3 | 0.0206±0.0080 | |
Level 4 | 0.0169±0.0079 | |
Level 5 | 0.0206±0.0106 | |
BMI | 0.0050±0.0004 | <0.001* |
HRT | 0.0707±0.0163 | <0.001* |
Alcohol consumption | <0.005* | |
<1 drink/month or unknown (ref) | – | |
≥1 drink/month and <1 drink/week | 0.0413±0.0118 | |
≥1 drink/week and <1 drink/day | 0.0148±0.0054 | |
≥1 drink per day | 0.0233±0.0106 | |
Dietary calciuma | 0.0079±0.0039 | 0.051 |
Omega 3 supplement use | 0.0211±0.0276 | 0.005* |
Marine derived dietary omega 3a | 0.0091±0.0276 | 0.743 |
HRT hormone replacement therapy use, BMI body mass index
p ≤0.05
Lumbar spine BMD square root transformed; dietary calcium fourth root transformed, marine-derived dietary omega 3 presented as the log of reported intakes plus 1 to correct for distribution skewness